Skip to product information
1 of 1

Combe

Vagisil 2% cream 20g

Vagisil 2% cream 20g

Regular price €12,83
Regular price €13,50 Sale price €12,83
Sale Sold out
Taxes included. Shipping calculated at checkout.
Logo Farmaci da banco

Vagisil 2% cream 20g: vulvar and perianal itching.

NET WEIGHT OF THE PRODUCT

20g

EAN

028700033

MINSAN

028700033

View full details

INDICATIONS

Vulvar and perianal itching.

 

ACTIVE INGREDIENTS

100 g of cream Active ingredients: Lidocaine base 2.0 g

 

EXCIPIENTS

Purified water, Stearic acid, Glycerin, Glycerin monostearate, Sulphonated castor oil, Triethanolamine, Diethylene glycol monoethyl ether, Isopropyl alcohol, Rose scent, Chlorothymol, Zinc oxide, Sodium dioctylsulfosuccinate.

 

CONTRAINDICATIONS AND SIDE EFFECTS

Hypersensitivity to lidocaine, or to other components of the product and substances closely related from a chemical point of view. Pediatric age. Pregnancy and breastfeeding.

 

DOSAGE

The product is intended for use by adult patients. Apply VAGISIL cream in a thin layer on the area to be treated: the application can be repeated up to 3 or 4 times a day, if necessary. Use only for short treatment periods

 

CONSERVATION

No special precautions.

 

WARNINGS

As with any local anaesthetic, any reactions and complications are more easily avoided by using the minimum effective dosages. Pay attention to the elderly and seriously ill patients. Do not use in case of damage to the mucous membranes, a condition in which it is necessary to consult a doctor. The use of products for topical use, especially if prolonged, can give rise to sensitization phenomena, in which case it is necessary to interrupt the treatment and, if necessary, institute suitable therapy. After a short period of treatment, without appreciable results or in case of suspected fungal infection, consult your doctor.

 

INTERACTIONS

Propanol prolongs the plasma half-life of lidocaine. Cimetidine may increase plasma levels of lidocaine.

 

SIDE EFFECTS

Only extremely improper use of the product can cause unwanted systemic effects. The appearance, albeit in rare cases, of allergic reactions is possible. Patients allergic to anesthetics derived from paraminobenzoic acid (procaine, tetracaine, benzocaine, etc.) present cross-reactivity towards lidocaine.

 

OVERDOSE

Symptoms of overdose are characterized by neuroexcitatory manifestations (tremors, convulsions followed by depression, respiratory failure and coma) and cardiovascular alterations with hypotension and bradycardia. Treatment is symptomatic. Any seizures can be controlled with the administration of barbiturates or short-acting benzodiazepines. The side effects reported above and the symptoms of overdose attributable to lidocaine have never occurred with the correct use of VAGISIL, respecting therapeutic indications and dosage.

 

PREGNANCY AND BREASTFEEDING

Preclinical studies conducted on rats and rabbits have not highlighted risks to the fetus. However, since no clinical data are available in pregnant women, the use of the product is to be considered contraindicated in this situation.

 

EFFECTS ON DRIVING ABILITY

Nobody.

1 of 4

Responsibility for content
This sheet contains information that is not intended to replace a diagnosis or medical advice, as only a doctor can write any prescription and give therapeutic indications. All contents must be understood and are of an exclusively informative nature and aimed exclusively at bringing to the attention of customers or potential customers in the pre-purchase phase of the products sold through this site. In case of pathologies, disorders or allergies it is always best to consult your doctor first.

Please note
The names of the products, the ingredients and the percentages indicated in the descriptions are purely indicative, they could be subject to changes or updates by the manufacturing companies. Due to the impossibility of adapting in real time to such updates, the photos and technical information of the products inserted on Dottortili.com may differ from those reported on the label or otherwise disseminated by the manufacturing companies. The only identification element is the ministerial code MINSAN. The online pharmacy Dottortili.com does not guarantee the truthfulness and timeliness of the information published and declines all responsibility for any errors, omissions or failure to update the same. Dottortili.com does not assume responsibility for damages of any nature that may arise from access to the published information.

Data source: Farmadati Italia
Website: www.farmadati.it

The Farmadati Italia Database is used by almost all pharmacies, parapharmacies, herbalists, health shops, large-scale retail trade, computerized doctors, etc. thanks to the company's historical guarantee of reliability, seriousness and professionalism on the national territory.

The Farmadati Italia Srl management system complies with the requirements of the UNI EN ISO 9001:2015 standards for quality management systems and UNI CEI ISO/IEC 27001:2017 for information security management systems.